
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Diethylcarbamazine
Introduction
| Diethylcarbamazine |
|---|
| HETRAZAN® WHO Prescribing Information |
| Description |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Overdosage |
| Dosage and Administration |
| How Supplied |
Synonyms and keywords: DEC
Overview
Overview
Diethylcarbamazine is an anthelmintic drug that does not resemble other antiparasitic compounds. It is a synthetic organic compound which is highly specific for several parasites and does not contain any toxic metallic elements.
Category
Category
Antiparasitic
US Brand Names
US Brand Names
HETRAZAN®
FDA Package Insert
FDA Package Insert
Description | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Dosage and Administration | How Supplied
Mechanism of Action
Mechanism of Action
Diethylcarbamazine is an inhibitor of arachidonic acid metabolism in filaria. This makes the filaria more susceptible to immune attack.
Uses
Uses
Diethylcarbamazine is indicated for treatment of individual patients with certain filarial diseases. These diseases include: lymphatic filariasis caused by infection with Wuchereria bancrofti, Brugia malayi, or Brugia timori; tropical pulmonary eosinophilia, and loiasis.
In cases of onchocerciasis, another common filarial parasite, the drug is not used. This is because the itching associated with the dead subcutaneous parasites causes intense and unbearable itching.
Diethylcarbamazine continues to be the mainstay for treatment of patients with lymphatic filariasis and loiasis. Diethylcarbamazine is also used in the prevention of dogheartworm Dirofilaria immitis.
References
References
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
